Suppr超能文献

扑米酮、苯巴比妥和苯乙基丙二酰胺:I. 小鼠体内各化合物的抗惊厥作用、神经毒性及治疗指数

Primidone, phenobarbital, and PEMA: I. Seizure protection, neurotoxicity, and therapeutic index of individual compounds in mice.

作者信息

Bourgeois B F, Dodson W E, Ferrendelli J A

出版信息

Neurology. 1983 Mar;33(3):283-90. doi: 10.1212/wnl.33.3.283.

Abstract

Neurotoxicity and protection against maximal electroshock and Metrazol seizures from primidone (PRM), phenobarbital (PB), and phenylethylmalonamide (PEMA) were determined in mice for each drug separately and expressed in terms of brain concentrations. Compared with PB, PEMA was 16 times less potent against electroshock and Metrazol seizures but only 8 times less toxic. Primidone was markedly less neurotoxic than PB and equally potent against electroshock, but PRM had no effect against Metrazol or bicuculline. PRM is a relatively nontoxic anticonvulsant with a different action than PB, and PEMA is both a weak and a relatively toxic anticonvulsant.

摘要

分别测定了小鼠体内扑米酮(PRM)、苯巴比妥(PB)和苯乙基丙二酰胺(PEMA)的神经毒性以及对最大电休克和戊四氮惊厥的保护作用,并以脑内浓度表示。与PB相比,PEMA对电休克和戊四氮惊厥的效力低16倍,但毒性仅低8倍。扑米酮的神经毒性明显低于PB,对电休克的效力相同,但PRM对戊四氮或荷包牡丹碱无作用。PRM是一种相对无毒的抗惊厥药,其作用与PB不同,而PEMA既是一种弱效又是一种相对有毒的抗惊厥药。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验